Where Are They Now: Chloe Jarratt
Where Are They Now?
Chloe Jarratt
When we first featured Chloe Jarratt five years ago, she was a nine-year-old in elementary school and taking ballet classes after a clinical trial for type 1 diabetes. She was bright, curious, and positive. Where is she today?
Chloe has built inspirational resilience and strength. Her mother, Amanda Jarratt, gave us an update on her daughter that, given in her own words, also makes a powerful case for the crucial need for ongoing diabetes research.
Chloe is a sassy, healthy 14-year-old teenager. She maintains straight As in all of her classes while playing volleyball for the JV team for her school and participating in numerous other extracurricular activities. She is managing her type 1 diabetes independently and is looking forward to implementing the 780g system [recently approved insulin pump technology] in the next few weeks.
Her sister, Claire, was devastatingly diagnosed with type 1 diabetes on Christmas Day in 2021 and with Celiac on Christmas Eve in 2022. Chloe has been an amazing mentor to her younger sister and has helped her adjust to a life with type 1 diabetes as easily as it can be done. Utilizing the Trial Net system, we have had their younger brother, Ethan, tested for the antibodies associated with type 1 diabetes. For now, he does not show an indication of having them; however, we will test him every three years.
The LaunchPad for Diabetes Innovation Fund, created by businessman and investor Paul Manning, continues to support collaborative translational research projects at UVA that propose innovative and viable solutions to curing, treating, or diagnosing diabetes.
READ MORE: https://giving.virginia.edu/stories/launchpad-ignites-breakthrough